NEW YORK (GenomeWeb) – UgenTec announced today that it has partnered with Serosep to add Serosep's EntericBio assay range to UgenTec's FastFinder platform.
The partnership will allow existing and new EntericBio customers to benefit from standardized diagnostic interpretation supported by artificial intelligence and automation.
UgenTec's FastFinder platform uses artificial intelligence to cut down workloads for lab technicians and improve reliability of diagnostic test results.
"FastFinder ... enables Serosep and our end users to standardize and automate results analysis on the EntericBio system," Serosep molecular diagnostics manager David Clancy said in a statement.
UgenTec also announced earlier this month that it has partnered with Hamilton Robotics as part of its Molecular Automation Network. In addition, the firm raised $9.3 million in a Series A funding round in March.